Beyond Immune Regulation- Complement Factor H Modulates Metabolism
By Deborah Ferrington
October 31, 2024 | 3-4 p.m. | HNO Lecture Hall
Deborah Ferrington, PhD, a renowned expert in vision research, has been appointed Chief Scientific Officer (CSO) of the Doheny Eye Institute in May 2022.
Dr. Ferrington is internationally recognized for her ground-breaking research on age-related macular degeneration (AMD), the leading cause of blindness among those over 60 in the developed world. In her new role, Dr. Ferrington will lead and expand the Institute’s research initiatives.
Dr. Ferrington brings over 20 years of academic research experience and was most recently a Professor and the Elaine and Robert Larson Endowed Vision Research Chair at the University of Minnesota. She holds a PhD in Biochemistry from the University of Kansas, where she also completed a postdoctoral fellowship. Her academic career is further distinguished by her more than 90 peer-reviewed publications and co-authorship of key scientific book chapters. She has been awarded multiple grants from the NIH, including funding from the National Eye Institute (NEI) and National Institute of Aging (NIA), as well as support from the Foundation Fighting Blindness and BrightFocus Foundation. Additionally, Dr. Ferrington serves as a Permanent Member of the NIH’s “Biology and Development of the Eye” Study Section.
